Desloratadine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Desloratadine
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Desloratadine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 16 USDMF, 14 CEP/COS, 23 EU WC, 3 KDMF, 11 NDC API, 35 Listed Suppliers, $ API Reference Price

53 API Suppliers
16 USDMF
14 CEP/COS
23 EU WC
3 KDMF
11 NDC API
35 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

277 FDF Dossiers, 24 FDA Orange Book, 153 Europe, 5 Canada, 41 South Africa, 54 Listed Dossiers

277 FDF Dossiers
24 FDA Orange Book
153 Europe
5 Canada
41 South Africa
54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 5MG, SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

TABLET;ORAL - 5MG
SOLUTION;ORAL - 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 2.5MG;120MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 2 Seqens, 3 DKSH, 7 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 1 ACG Worldwide, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 36 Disintegrants & Superdisintegrants, 34 Controlled & Modified Release, 34 Direct Compression, 31 Taste Masking, 30 Granulation, 26 Thickeners and Stabilizers, 25 Lubricants & Glidants, 24 Film Formers & Plasticizers, 24 Solubilizers, 21 Chewable & Orodispersible Aids, 19 Parenteral, 16 Co-Processed Excipients, 16 Topical, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 1 Soft Gelatin

84 Fillers, Diluents & Binders
60 Coating Systems & Additives
36 Disintegrants & Superdisintegrants
34 Controlled & Modified Release
34 Direct Compression
31 Taste Masking
30 Granulation
26 Thickeners and Stabilizers
25 Lubricants & Glidants
24 Film Formers & Plasticizers
24 Solubilizers
21 Chewable & Orodispersible Aids
19 Parenteral
16 Co-Processed Excipients
16 Topical
8 Emulsifying Agents
7 API Stability Enhancers
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
4 Rheology Modifiers
3 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 114 Finished Drug Prices, 6 Annual Reports

3 US Medicaid Prescriptions
114 Finished Drug Prices
6 Annual Reports

MARKET PLACE

27 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

27 APIs
10 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

7 Health Canada Patents

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 USP, 17 Others

2 EDQM
4 USP
17 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 912 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Bayer Inc.

filter Patent Reset all filters

7 All

01 12267136

02 32294352

03 12325014

04 22333528

filter Product Reset all filters

7 All

01 7Desloratadine

filter Dosage Reset all filters

7 All

01 4Syrup

02 3Tablet

filter Exp Date Reset all filters

7 All

01 12018-02-06

02 32018-07-01

03 22019-05-27

04 12019-07-08

Product Main Page

01

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-02-06

Date Granted : 2000-11-28

Desloratadine

Brand Name : AERIUS

Patent Number : 2267136

Filing Date : 1998-02-06

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-02-06

Date Granted : 2000-11-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Desloratadine

Brand Name : AERIUS

Patent Number : 2294352

Filing Date : 1998-07-01

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-05-27

Date Granted : 2002-07-02

Desloratadine

Brand Name : AERIUS

Patent Number : 2333528

Filing Date : 1999-05-27

Strength per Unit : 0.5 mg / ml

Dosage Form : Syrup

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-05-27

Date Granted : 2002-07-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Desloratadine

Brand Name : AERIUS

Patent Number : 2294352

Filing Date : 1998-07-01

Strength per Unit : 0.5 mg / ml

Dosage Form : Syrup

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-05-27

Date Granted : 2002-07-02

Desloratadine

Brand Name : AERIUS KIDS

Patent Number : 2333528

Filing Date : 1999-05-27

Strength per Unit : 0.5 mg / ml

Dosage Form : Syrup

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-05-27

Date Granted : 2002-07-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Desloratadine

Brand Name : AERIUS KIDS

Patent Number : 2294352

Filing Date : 1998-07-01

Strength per Unit : 0.5 mg / ml

Dosage Form : Syrup

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-01

Date Granted : 2008-05-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Bayer Inc.

Desloratadine

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-07-08

Date Granted : 2002-05-28

Desloratadine

Brand Name : AERIUS

Patent Number : 2325014

Filing Date : 1999-07-08

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-07-08

Date Granted : 2002-05-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!